Top Story

Pembrolizumab appears safe, effective in advanced gastric cancer

January 27, 2015

The novel agent pembrolizumab demonstrated promising antitumor activity and manageable toxicity in patients with advanced gastric cancer, according to study results presented at the Gastrointestinal Cancers Symposium.

Pembrolizumab (Keytruda, Merck) — which is being studied in a variety of several cancer types — is a monoclonal antibody that blocks the PD-1 pathway.

Kim F. Rhoads, MD In the Journals

Integrated health care may eliminate racial disparities in colon cancer survival

January 26, 2015
Providing fair, high-quality, evidence-based care can eliminate racial disparities in survival outcomes among patients with colon cancer, according to results of a…
Breaking News

FDA approves Triferic for iron replacement in patients with chronic kidney disease

January 26, 2015
The FDA today approved Triferic to treat iron loss in patients with chronic kidney disease who are on dialysis, according to the drug’s manufacturer.Triferic…
Mikkael A. Sekeres In the Journals

Azacitidine, lenalidomide treatment appears safe for myelodysplastic syndrome, AML

January 26, 2015
A sequential treatment combination of lenalidomide and azacitidine appeared active in and safe for patients with high-risk myelodysplastic syndrome or acute myeloid…
FDA approvals

FDA grants orphan drug status to ovarian cancer treatment

January 26, 2015
The FDA granted orphan drug designation to liposomal encapsulated paclitaxel, or LEP-ETU, an ovarian cancer treatment in development by Insys Therapeutics Inc., the…
More News Headlines »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
Meeting News Coverage Video
Genome editing demonstrated wide application for blood disorders

Genome editing demonstrated wide application for blood disorders

January 4, 2015
SAN FRANCISCO — Ralph Green, MD, PhD, FRCPath, medical director of the UC Davis Health System Medical…
More »
CME CNE
Stem Cell Transplant for AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 3 Stem Cell Transplant for MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain to…
More »